|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:affects
|
animals
humans
|
|
gptkbp:causedBy
|
gptkb:Leishmania_parasite
|
|
gptkbp:complication
|
death
disfigurement
secondary infections
|
|
gptkbp:diagnosedBy
|
PCR
microscopy
serology
|
|
gptkbp:firstDescribed
|
1903
|
|
gptkbp:hasIncubationPeriod
|
weeks to months
|
|
gptkbp:hasReservoir
|
gptkb:dog
humans
rodents
|
|
gptkbp:hasType
|
gptkb:mucocutaneous_leishmaniasis
gptkb:visceral_leishmaniasis
leishmaniasis
|
|
gptkbp:hasVaccine
|
no licensed human vaccine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Leishmaniasis
|
|
gptkbp:ICD-10_code
|
gptkb:B55
|
|
gptkbp:mortalityRate
|
high in untreated visceral leishmaniasis
|
|
gptkbp:namedAfter
|
gptkb:William_Boog_Leishman
|
|
gptkbp:prevalence
|
gptkb:Africa
gptkb:Middle_East
gptkb:South_America
subtropical regions
tropical regions
southern Europe
|
|
gptkbp:prevention
|
personal protective equipment
insecticide-treated nets
vector control
|
|
gptkbp:relatedTo
|
gptkb:Trypanosomiasis
|
|
gptkbp:studiedBy
|
tropical medicine
|
|
gptkbp:symptom
|
fever
enlarged liver
enlarged spleen
skin sores
weight loss
|
|
gptkbp:transmittedBy
|
sandfly
|
|
gptkbp:treatment
|
gptkb:amphotericin_B
gptkb:miltefosine
gptkb:paromomycin
antimonial drugs
|
|
gptkbp:vectorFor
|
gptkb:Phlebotomine_sandflies
|
|
gptkbp:WHOpriority
|
neglected tropical disease
|
|
gptkbp:zoonotic
|
true
|
|
gptkbp:bfsParent
|
gptkb:Sir_William_Boog_Leishman
gptkb:disease
|
|
gptkbp:bfsLayer
|
4
|